P
Park Therapeutics was a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for Parkinson's disease. The company specialized in creating treatments designed to address the underlying pathology of the neurodegenerative disorder. Its pipeline aimed to offer disease-modifying options for patients with unmet medical needs.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Park Therapeutics was a clinical-stage biopharmaceutical company focused on developing novel small molecule therapeutics for Parkinson's disease. The company specialized in creating treatments designed to address the underlying pathology of the neurodegenerative disorder. Its pipeline aimed to offer disease-modifying options for patients with unmet medical needs.